KYMR KYMERA THERAPEUTICS
Permanent stock page ↗Health Care · Russell 2000
Next earnings: not announced yet
What 29 analyst firms say about KYMERA THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
30 rated views · 32 analyst/firm records · 29 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8059
- Russell 2000 · Safest consensus · 6MGood · #10 in the index87
Recent analyst activity · last 90 days
Our tracked history has 21 reports on KYMR from 18 analyst firms in the last 90 days (29 firms in the past year).
Comparing each firm's latest target with its previous one: 8 raised their price target, 5 left it unchanged and 2 have their first observed target in the past year.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: Barclays raised its target from $139.00 (set 6 Aug 2026) to $170.00 on 2 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | Kalpit Patel | Buy | 29 Jun 2026 | 155.00 USD |
| B Riley Securities | Mayank Mamtani | Buy | 26 Jun 2026 | 155.00 USD |
| Bank of America Securities | Tazeen Ahmad | Buy | 14 Sep 2026 | 144.00 USD |
| Barclays | Eliana Merle | Buy | 6 Aug 2026 | 139.00 USD |
| Brookline Capital Markets | Leah R Cann | Buy | 5 Aug 2026 | Conflicting reports · excluded |
| BTIG | Jeet Mukherjee | Buy | 29 Oct 2026 | 139.00 USD |
| Canaccord Genuity | Edward Nash | Buy | 26 Jun 2026 | 129.00 USD |
| Citigroup | Geoff Meacham | Buy | 5 Oct 2026 | 150.00 USD |
| Deutsche Bank | David Hoang | Hold | 30 Jul 2026 | 120.00 USD |
| Guggenheim | Bradley P Canino | Buy | 29 Oct 2026 | 170.00 USD |
| H.C. Wainwright | Andrew S Fein | Buy | 6 Aug 2026 | 134.00 USD |
| Jefferies | Faisal Khurshid | Buy | 22 Jul 2026 | 150.00 USD |
| Jefferies | Kelly Shi | Buy | 16 Mar 2026 | 110.00 USD |
| JPMorgan | Brian Cheng | Buy | 10 Dec 2025 | 125.00 USD |
| Leerink Partners | Thomas J Smith | Buy | 5 Aug 2026 | 130.00 USD |
| Loop Capital | Leah Rush Cann | — | 29 Oct 2026 | 132.00 USD |
| Mizuho | Joseph Catanzaro | Buy | 16 Jul 2026 | 140.00 USD |
| Morgan Stanley | James Quigley | Buy | 27 Oct 2026 | 146.00 USD |
| Morgan Stanley | Judah Frommer | Buy | 6 Aug 2026 | 135.00 USD |
| Oppenheimer | Jeff Jones | Buy | 29 Oct 2026 | 140.00 USD |
| Piper Sandler | Biren Amin | Buy | 23 Sep 2026 | 140.00 USD |
| Raymond James | Thomas Deal | Buy | 29 Oct 2026 | 140.00 USD · 8 Oct 2026 |
| RBC Capital Markets | Brian Abrahams | Hold | 30 Oct 2026 | 116.00 USD |
| Stephens | Sudan Loganathan | Buy | 2 Mar 2026 | 100.00 USD |
| Stifel | Alex Thompson | Buy | 22 Sep 2026 | 152.00 USD |
| TD Cowen | Tyler Van Buren | Buy | 24 Aug 2026 | — |
| Truist | Srikripa Devarakonda | Buy | 30 Oct 2026 | 150.00 USD |
| UBS | David Dai | Buy | 15 Jul 2026 | 128.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Derek Archila | Buy | 27 Aug 2026 | 151.00 USD |
| Wolfe Research | Andy Chen | Buy | 10 Sep 2026 | 180.00 USD |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 113.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:08 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.